The biopharmaceutical company AstraZeneca has released data on what is now the third promising vaccine candidate against COVID-19—and it has several advantages over those of its competitors, Pfizer and Moderna.
Nov 25, 2020
0
3
At least three new COVID-19 vaccine candidates are already in the pipeline, with a roll-out expected early in the new year. But on Monday, experts attending a meeting of an advisory committee to the U.S. Centers for Disease ...
Nov 24, 2020
2
5
The United States hopes to begin coronavirus vaccinations in early December, a top government health official said Sunday, the latest positive news to emerge even as cases surge across the worst-hit nation and elsewhere around ...
Nov 23, 2020
0
2
Americans were on Friday facing a growing raft of coronavirus restrictions, even as pharma giant Pfizer and partner BioNTech prepared to file an emergency request to roll out their vaccine.
Nov 20, 2020
0
1
Researchers at the University of Tennessee Health Science Center working with colleagues at the University of New Mexico have identified three drugs, already approved for other uses in humans, as possible therapeutics for ...
Nov 18, 2020
0
15
As the weather cools, the number of infections of the COVID-19 pandemic are rising sharply. Hamstrung by pandemic fatigue, economic constraints and political discord, public health officials have struggled to control the ...
Nov 18, 2020
0
15
American biotech firm Moderna has released early results from its phase 3 clinical trials, announcing in a press release on Monday (US time) that its COVID vaccine has an efficacy of 94.5%, according to an "interim analysis" ...
Nov 17, 2020
0
1
Plans for vaccination programmes began taking shape in Europe and the United States following recent breakthroughs, but surging coronavirus caseloads prompted gruelling new restrictions, with Austria taking the unpopular ...
Nov 17, 2020
0
1
(HealthDay)—Scientists are reporting early success with an experimental herpes vaccine that uses a genetically modified version of the virus.
Nov 16, 2020
0
18
Dozens of companies, from biotech start-ups to Big Pharma, are racing to develop a safe and effective COVID-19 vaccine, both to meet urgent medical need and for the potential payday.
Nov 16, 2020
0
4
